* K: Session in Korean
| Time | [ROOM 1AB] Grand Ballroom |
[ROOM 1C] Grand Ballroo |
[ROOM 2AB] Park Ballroom |
[ROOM 2C] Park Ballroom |
Time |
|---|
* K: Session in Korean
| Time | [ROOM 3] Studio123 |
[ROOM 4A] Studio4 |
[ROOM 4B] Studio5 |
[ROOM 4C] Studio6 |
[ROOM 4D] Studio7 |
Exhibition Hall |
Time |
|---|
| 07:30-08:00 |  KAHBPS Symposium 1Expanding Indications for Hepatic Resection in HCC07:30-08:50 |
KASL Branch EMW 5Busan-Ulsan-Gyeongnam (K) 07:30-08:00 |
KASL Branch EMW 6 Gangwon (K) 07:30-08:00 |
KASL Branch EMW 4Jeonbuk (K) 07:30-08:00 |
07:30-08:00 | ||
|---|---|---|---|---|---|---|---|
| 08:00-09:00 | Poster Oral Presentation 08:00-09:00 |
08:00-09:00 | |||||
| 09:10-10:30 | KAHBPS Symposium 2How AI Is Transforming Future Liver Surgery 09:10-10:30 |
Free Paper 8 09:10-10:30 |
Free Paper 9 09:10-10:30 |
Free Paper 10 09:10-10:30 |
Free Paper 11 09:10-10:30 |
Booth & Poster Exhibition |
09:10-10:30 |
| 10:30-10:50 | Coffee Break 10:30-10:50 |
10:30-10:50 | |||||
| 12:20-13:10 | Luncheon Symposium 12 12:20-13:10 |
12:20-13:10 | |||||
| 13:50-15:10 | KAHBPS Symposium 3How to Approach Benign Liver Tumors 13:50-15:10 |
Free Paper 12 13:50-15:10 |
Free Paper 13 13:50-15:10 |
Free Paper 14 13:50-15:10 |
13:50-15:10 | ||
| 16:20-17:50 | EALA 2026 Breakout Session [Group 1] 16:20-17:50 |
EALA 2026 Breakout Session [Group 2] 16:20-17:50 |
EALA 2026 Breakout Session [Group 3] 16:20-17:50 |
EALA 2026 Breakout Session [Group 4] 16:20-17:50 |
16:20-17:50 | ||
09:10-10:30
KASL Symposium 5
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Alcohol-Related Liver Disease (MetALD)
Chair: Stefano Romeo (Karolinska Institutet, Sweden), Yong Kyun Cho (Sungkyunkwan Univ.)
- 09:10-09:30
-
Outcomes and Prognosis in MASLD: Genetic Determinants from Single-Nucleotide Polymorphisms to Beyond
Stefano Romeo (Karolinska Institutet, Sweden)
- 09:30-09:50
-
MASLD vs. MetALD: Interactions between Alcohol Intake and Metabolic Risk Factors
Sang Gyune Kim (Soonchunhyang Univ.)
- 09:50-10:10
-
Standardizing Histological Grading and Staging in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Clinical Trials: Consensus Position Statements from the International Pathology Group
Young Nyun Park (Yonsei Univ.)
- 10:10-10:30
-
Future of MASH Treatment: GLP-1/GIP Agonists, Resmetirom, and Beyond
Dae Won Jun (Hanyang Univ.)
10:50-11:20
State-of-the-Art Lecture
Chair: Soon Koo Baik (Yonsei Univ. Wonju)
- 10:50-11:20
-
Developing Drugs for Liver Fibrosis
David A. Brenner (Sanford Burnham Prebys, USA)
11:20-12:20
Plenary Presentation: Late-Breaking Abstracts
Chair: June Sung Lee (Inje Univ.), Jong Eun Yeon (Korea Univ.), Kwang-Woong Lee (Seoul National Univ.)
13:10-13:50
2026 KASL Clinical Practice Guidelines
Chair: Young-Suk Lim (Univ. of Ulsan), Tatsuya Kanto (Japan Institute for Health Security, Japan)
- 13:10-13:50
-
Management of Chronic Hepatitis B: 2026 KASL Update
In Hee Kim (Jeonbuk National Univ.)
13:50-15:10
KASL Symposium 7
Liver Cirrhosis, Portal Hypertension, and Acute-on-Chronic Liver Failure (ACLF): Advancing the Continuum of Care from Organ Failure to Recovery
Chair: Seng-Gee Lim (National Univ. of Singapore, Singapore), Jae Young Jang (Soonchunhyang Univ.)
- 13:50-14:10
-
ACLF across Definitions: Harmonizing Diagnostic Criteria and Organ Failure Assessment
Jung Hee Kim (Hallym Univ.)
- 14:10-14:30
-
Management of Acute Kidney Injury in ACLF: Current Evidence and Unmet Needs
Rakhi Maiwall (Institute of Liver and Biliary Sciences, India)
- 14:30-14:50
-
Achieving Recompensation in Cirrhosis: Evidence and Future Directions
Yu Jun Wong (Duke-NUS Medical School, Singapore)
- 14:50-15:10
-
ACLF: Transplant before It’s Too Late
Dong-Sik Kim (Korea Univ.)
15:20-16:20
The Liver Week 2026 Debrief
Chair: Jeong-Hoon Lee (KASL), Jun Yong Park (KLCA), Jongman Kim (KAHBPS), YoungRok Choi (KLTS)
- 15:20-15:35
-
KASL
- 15:35-15:50
-
KLCA
- 15:50-16:05
-
KAHBPS
- 16:05-16:20
-
KLTS
08:00-09:00
KASL-AASLD Morning Workshop
The Evolving Landscape of Liver Transplantation: From Policy to Practice
Chair: Jung-Hwan Yoon (Seoul National Univ.), W. Ray Kim (Mayo Clinic, USA)
- 08:00-08:20
-
Expanding the Donor Pool: Donation after Circulatory Death, Donation after Brain Death, and Ex-vivo Graft Management Strategies
Parissa Tabrizian (Icahn School of Medicine at Mount Sinai, USA)
- 08:20-08:40
-
Optimizing Allocation and Policy Models: Balancing Equity and Efficiency in Opt-in vs. Opt-out Systems
Willscott Naugler (Oregon Health & Science Univ., USA)
- 08:40-09:00
-
Expanding Recipient Criteria for HCC: Lessons from Living Donor Liver Transplantation and Regional Experiences
Suk Kyun Hong (Seoul National Univ.)
09:10-10:30
KASL Symposium 6
Transformative Strategies for Functional Cure of Chronic Hepatitis B: Novel Insights and Future Perspectives
Chair: Han Chu Lee (Univ. of Ulsan), Man-Fung Yuen (The Univ. of Hong Kong, Hong Kong)
- 09:10-09:30
-
Antisense Oligonucleotides vs. siRNA: Which Represents the Better Option for HBV Treatment?
Man-Fung Yuen (The Univ. of Hong Kong, Hong Kong)
- 09:30-09:50
-
Gene Therapies to Achieve Functional Cure in Chronic Hepatitis B
Edward Gane (Univ. of Auckland, New Zealand)
- 09:50-10:10
-
Do Capsid Inhibitors Have a Role in Achieving HBV Cure?
Sang Hoon Ahn (Yonsei Univ.)
- 10:10-10:30
-
Endpoints of Chronic Hepatitis B Therapy: Partial, Functional, and Sterilizing Cure
Seng-Gee Lim (National Univ. of Singapore, Singapore)
13:50-15:10
Advances in Experimental Hepatology
Chair: Yoon Mee Yang (Sungkyunkwan Univ.), Hyun Young Kim (Dankook Univ.)
- 13:50-14:20
-
Reversibility of Activated Portal Fibroblast in Cholestatic Liver Fibrosis Regression
Tatiana Kisseleva (Univ. of California San Diego, USA)
- 14:20-14:50
-
At the Frontline of Metabolic Liver Disease: Stress and Inflammation
Michael Karin (Sanford Burnham Prebys, USA)
- 14:50-15:10
-
Transcriptional Regulation of Hepatic Stellate Cell Phenotypes during Liver Fibrosis Resolution
Wonseok Lee (Gachon Univ.)
08:30-09:00
2026 KLCA Practice Guidance of SBRT: Expert Consensus (*K)
Chair: Sang Hoon Park (Hallym Univ.)
- 08:30-09:00
-
Stereotactic Body Radiation Therapy: Expert Consensus-Based Practical Recommendations of KLCA
Sang Min Yoon (Univ. of Ulsan)
09:10-10:30
KLCA Symposium 3
Therapeutic Update and Emerging Therapy in HCC
Chair: Hee Chul Park (Sungkyunkwan Univ.), Do Young Kim (Yonsei Univ.)
- 09:10-09:30
-
Carbon Ion Therapy: The Next Step in Precision Radiotherapy
Kei Shibuya (Gunma Univ., Japan)
- 09:30-09:50
-
Advances in Interventional Oncology: From TACE to TARE and Beyond
Gyoung Min Kim (Yonsei Univ.)
- 09:50-10:10
-
Novel Molecular and Cellular Therapies in HCC: The Next Wave
Stephen Lam Chan (The Chinese Univ. of Hong Kong, Hong Kong)
- 10:10-10:30
-
Multidisciplinary Horizons: From Immune Checkpoint Blockade to Liver Transplantation
Ju Dong Yang (Cedars-Sinai Medical Center, USA)
07:30-08:00
Mini Special Interest Group 2. The KASL Abdominal Ultrasound Study Group (K)
Chair: Moon Young Kim (Yonsei Univ. Wonju)
- 07:30-07:50
-
Ultrasound Assessment of Liver Fibrosis: Comparison with 2D Shear Wave Elastography and FibroScan
Jeong-Ju Yoo (Soonchunhyang Univ.)
- 07:50-08:00
-
Discussion
08:00-09:00
Artificial Intelligence (AI) in Hepatology
Chair: Chang Hyeong Lee (Daegu Catholic Univ.), Kang Mo Kim (Univ. of Ulsan)
- 08:00-08:20
-
AI-Based Multi-Omics Integration for Precision Hepatology
Junil Kim (Soongsil Univ.)
- 08:20-08:40
-
Deep Learning and Digital Pathology in HCC: From Diagnosis to Prognosis
Sunghak Lee (The Catholic Univ. of Korea)
- 08:40-09:00
-
Multimodal AI and Large Language Models for Cancer Research
Seng Chan You (Yonsei Univ.)
09:10-10:30
Special Interest Group 2
The KASL Alcohol-Related Problem Study Group
Chair: Jae Young Jang (Soonchunhyang Univ.), Won-Il Jeong (KAIST)
- 09:10-09:30
-
Update on Clinical Trial Design and Endpoints in Alcohol-Associated Liver Disease
Heechul Nam (The Catholic Univ. of Korea)
- 09:30-09:50
-
Immune Dysfunction in Alcohol-Associated Liver Disease
Wonhyo Seo (Ewha Womans Univ.)
- 09:50-10:10
-
Gut–Liver Axis in Alcohol-Associated Liver Disease: Mechanistic Insights and Translational Implications
Ki-Tae Suk (Hallym Univ.)
- 10:10-10:30
-
Discussion
13:50-15:10
Special Interest Group 3
The KASL Steatotic Liver Disease Study Group
Novel Technologies in Steatotic Liver Disease (SLD) Research
Chair: Yong Kyun Cho (Sungkyunkwan Univ.) Jin-Woo Lee (Inha Univ.)
- 13:50-14:10
-
MASH Pathogenesis through Single-Cell Analysis
Murim Choi (Seoul National Univ.)
- 14:10-14:30
-
Liver Organoid Model for Investigating SLD
Yohan Kim (Sungkyunkwan Univ.)
- 14:30-14:55
-
Advances in SLD Diagnosis Using 3D Multiparametric Imaging
Chulhong Kim (POSTECH)
- 14:55-15:10
-
Discussion
07:30-08:50
KAHBPS Symposium 1
Expanding Indications for Hepatic Resection in HCC: Challenging the Boundaries
Chair: Hee Chul Yu (Jeonbuk National Univ.), Jaehong Jeong (Soonchunhyang Univ.)
- 07:30-07:50
-
Resection Beyond BCLC Guidelines: Surgical Outcomes in BCLC B or C
Young Chul Yoon (The Catholic Univ. of Korea)
- 07:50-08:10
-
Bridging with Locoregional Therapy: Role of TARE, TACE in Downstaging
Dongho Hyun (Sungkyunkwan Univ.)
- 08:10-08:30
-
From Unresectable to Resectable: How Immunotherapy Is Changing the Surgical Landscape
Jeong-Ju Yoo (Soonchunhyang Univ.)
- 08:30-08:50
-
Surgical Considerations after Neoadjuvant or Conversion Therapy
Kiyoshi Hasegawa (The Univ. of Tokyo, Japan)
09:10-10:30
KAHBPS Symposium 2
How AI Is Transforming Future Liver Surgery
Chair: Sung Su Yun (Yeungnam Univ.), Dongho Choi (Hanyang Univ.)
- 09:10-09:30
-
Why Surgeons Need AI: A Clinical Perspective
Namkee Oh (Sungkyunkwan Univ.)
- 09:30-09:50
-
Augmented Reality for Preoperative Planning and Intraoperative Visualization
Maki Sugimoto (Teikyo Univ. Okinaga Research Institute, Japan)
- 09:50-10:10
-
Real-Time AI Navigation in Minimally Invasive Surgery
Daichi Kitaguchi (Univ. of Tsukuba, Japan)
- 10:10-10:30
-
Intraoperative Assessment and AI-Assisted Coaching System in Hepatobiliary Surgery
Xin Wang (The Chinese Univ. of Hong Kong, Hong Kong)
13:50-15:10
KAHBPS Symposium 3
How to Approach Benign Liver Tumors
Chair: Jin-Young Jang (Seoul National Univ.), Dong-Hwan Jung (Univ. of Ulsan)
- 13:50-14:10
-
Advanced Imaging Modalities and Differential Diagnosis: A Radiologist’s Perspective
Dong Ik Cha (Sungkyunkwan Univ.)
- 14:10-14:30
-
Risk Stratification and Indication for Surgical Resection: A Surgeon’s Perspective
Euisoo Han (The Catholic Univ. of Korea)
- 14:30-14:50
-
Minimally Invasive Approaches in the Management of Benign Liver Tumors
Kyeong Sik Kim (Hanyang Univ.)
- 14:50-15:10
-
Surveillance after Surgery Outcomes and Recurrence: A Surgeon’s Perspective
Min-Su Park (Kyung Hee Univ.)
07:30-08:00
KASL Branch Early Morning Workshop 5 [Busan-Ulsan-Gyeongnam] (*K)
Chair: Sung Jae Park (Inje Univ.)
- 07:30-07:45
-
Unmet Needs in Current Treatment of Chronic Hepatitis B
Sang Yi Moon (Dong-A Univ.)
- 07:45-08:00
-
Working Toward Functional Cure of Chronic Hepatitis B
Jeong Heo (Pusan National Univ.)
07:30-08:00
KASL Branch Early Morning Workshop 6 [Gangwon] (*K)
- 07:30-08:00
-
TBD
07:30-08:00
KASL Branch Early Morning Workshop 7 [Jeonbuk] (*K)
Chair: Eun Young Cho (Wonkwang Univ.)
- 07:30-08:00
-
Risk Stratification for Hepatocellular Carcinoma in MASLD: Who Should Be Screened?
Chang Hun Lee (Jeonbuk National Univ.)
